JB Chemicals and Pharmaceuticals Ltd on Tuesday (February 4) reported a 21.6% year-on-year (YoY) surge in net profit at ₹162.5 crore for the third quarter that ended December 31, 2024, compared to ₹133.6 crore in Q3 FY24.CompanyValueChange%ChangeAlso Read: Dhanlaxmi Bank Q3 Results | Net profit zooms over 6x to ₹20 crore with double-digit NII growthThe company’s revenue from operations increased 14.1% to ₹963.5 crore against ₹844.5 crore in the corresponding period of the preceding fiscal. At the operating level, EBITDA was up 14.1% to ₹254.5 crore in the third quarter of this fiscal over ₹223.1 crore year-on-year.
The EBITDA margin remained the same at 26.4% in the reporting quarter versus 26.4% in the year-ago quarter. EBITDA is earnings before interest, tax, depreciation, and amortisation.Also Read: Metropolis Health Q3 net profit rises 15% to ₹31 crore, revenue up 11%The results came after the close of the market hours. Shares of JB Chemicals & Pharmaceuticals Ltd ended at ₹1,737.20, up by ₹23.10, or 1.35%, on the BSE.(Edited by : Shoma Bhattacharjee)First Published: Feb 4, 2025 7:41 PM IST
